Anthropic Faces Lawsuit Over Misleading Claude Pricing
A new class-action alleges that Anthropic overstated Claude Max usage limits and the promised savings. The case could...
A concise guide to planning Social Security timing from a 30s perspective, covering factors that affect when to start and how it influences lifetime benefits.
20,404 articlesA new class-action alleges that Anthropic overstated Claude Max usage limits and the promised savings. The case could...
A recent Insider Form 4 reveals Nayax Ltd.'s President sold 4,500 shares after exercising options. Here’s how to read...
The JPMORGAN Nasdaq Equity Premium Income ETF blends a Nasdaq-heavy stock sleeve with a covered-call strategy to deli...
As memory cycles swing, the safest play in July may not be the pure-play chips you expect. This article explains why ...
As 2026 unfolds, investors eye three key covered call ETFs for steady monthly income. This analysis compares ISPY, JE...
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
Is Pfizer stock undervalued in the crowded healthcare space? This deep dive weighs cash flow, dividends, pipeline pot...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
GitLab delivered solid revenue growth but offered modest profitability guidance, triggering a sharp stock move. This ...
This article lays out a grounded three-year path for Tesla, focusing on core EV leadership, software-based autonomy r...
Nebius stock fell today after the company announced debt issuance to fund its infrastructure push and key AI partners...
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...